Impact BioMedical, Inc. (IBO)
4.68
-0.16
(-3.31%)
USD |
NYAM |
Oct 06, 16:00
4.61
-0.07
(-1.50%)
After-Hours: 07:50
Impact BioMedical Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | -1.938 |
| June 30, 2025 | -2.162 |
| March 31, 2025 | 2.379 |
| December 31, 2024 | 2.084 |
| September 30, 2024 | 0.2554 |
| June 30, 2024 | 0.5755 |
| March 31, 2024 | 0.5271 |
| December 31, 2023 | 0.4787 |
| September 30, 2023 | 0.4444 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.4256 |
| March 31, 2023 | 0.3809 |
| December 31, 2022 | 0.3224 |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 0.3421 |
| September 30, 2021 | |
| June 30, 2021 | 0.2139 |
| March 31, 2021 | |
| December 31, 2020 | 0.0279 |
| September 30, 2020 | 1.210 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| LENZ Therapeutics, Inc. | 0.0026 |
| Enveric Biosciences, Inc. | 0.00 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 16.74M |
| Total Liabilities (Quarterly) | 2.733M |
| Shareholders Equity (Quarterly) | 10.77M |
| Current Ratio | 0.1565 |
| Net Debt Paydown Yield | 3.69% |